SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amcis’ arm enters into co-investment agreement with Japanese customer

06 Jun 2025 Evaluate

Dishman Carbogen Amcis’ wholly owned subsidiary -- Carbogen Amcis AG has entered into a co-investment agreement of more than CHF 25 million with a long-standing Japanese customer to expand manufacturing capabilities at its sites in Aarau and Neuland, Switzerland.

The investment will support the production of a drug linker for a commercial antibody-drug conjugate (ADC), enabling Carbogen Amcis to meet rising global demand. This project builds on a previous joint funding agreement between Carbogen Amcis and the same customer in April 2021 to develop a site extension at the Bubendorf site in Switzerland, reinforcing the strength of the relationship and their shared commitment to long-term growth.

Carbogen Amcis is recognised for its robust capabilities in handling highly potent compounds, offering end-to-end support from process development to commercial supply. The new investments will further strengthen the company’s infrastructure to deliver high-quality manufacturing services in line with cGMP and global regulatory expectations.

Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators.


Dishman Carbogen Amc Share Price

171.65 4.10 (2.45%)
21-Apr-2026 12:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.20
Dr. Reddys Lab 1219.55
Cipla 1231.55
Zydus Lifesciences 928.40
Lupin 2322.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×